Los Angeles Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Los Angeles Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,319	Closed	-$1.33M	–	1579
2020 Q3	$1.33M	Buy	25,319 +10	+0%	+$414	0.01%	708
2020 Q2	$842K	Buy	25,309 +11,039	+77%	+$351K	﹤0.01%	912
2020 Q1	$388K	Buy	+14,270	New	+$397K	﹤0.01%	982
2017 Q4	–	Sell	-61,680	Closed	-$1.14M	–	1428
2017 Q3	$1.14M	Buy	+61,680	New	+$1.03M	0.01%	778
2016 Q4	–	Sell	-31,930	Closed	-$373K	–	1270
2016 Q3	$373K	Sell	31,930 -175	-0.5%	-$2.06K	﹤0.01%	994
2016 Q2	$347K	Buy	+32,105	New	+$331K	﹤0.01%	1006
2014 Q2	–	Sell	-17,295	Closed	-$201K	–	1318
2014 Q1	$201K	Buy	+17,295	New	+$293K	﹤0.01%	1188

Los Angeles Capital Management's MNTA Position: Q4 2020 in Review

Los Angeles Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 25,319 shares — an estimated $1.33M sold.

Los Angeles Capital Management first reported a position in MNTA in Q1 2014 and held it in 7 quarters. The position peaked at $1.33M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Los Angeles Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Los Angeles Capital Management sold 25,319 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.33M.
Los Angeles Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 7 quarters.
Los Angeles Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.33M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Los Angeles Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.